Search for Clinical Trial Results
B Cell Prolymphocytic Leukemia - 14 Studies Found
Status | Study |
Not yet recruiting |
Study Name: Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma Condition:
|
Recruiting |
Study Name: Study to Evaluate Safety and Tolerability of XmAb13676 in Patients With CD20-expressing Hematologic Malignancies Condition:
|
Withdrawn |
Study Name: Phase 1 Study Evaluating ZEN003365 in Relapsed/Refractory Lymphoproliferative Malignancies or Relapsed/Refractory AML Condition:
Date: 2014-08-28 Interventions: Drug: ZEN003365 |
Active, not recruiting |
Study Name: Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies Condition: Leukemia Date: 2010-03-25 Interventions: Drug: Nelarabine Starting dose 200 mg/m2 for 5 day continuous infusion administered via a central cathet |